Prognosis in juvenile uveal Melanoma

被引:0
|
作者
不详
机构
来源
OPHTHALMOLOGE | 2017年 / 114卷 / 12期
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Following the history of mechanics (Dugas in A history of mechanics, Dover, New York, 1988), we read that Poisson's theorem figured in the 1811 edition of the celebrated M,canique Analytique. Indeed, as it can be observed in the classical textbooks, Poisson brackets formulation is one of the cardinal chapters of analytical mechanics. Given the natural motivation to accommodate variable-mass systems at the level of classical analytical mechanics, we will herein direct our attention toward Poisson brackets formulation. To wit, considering the case of a position-dependent mass particle, in which we will assume that the absolute velocity of mass ejection or aggregation is a linear function of the generalized velocity, we will endeavor to provide such position-dependent mass problems with an appropriate Poisson brackets formulation. To our very best knowledge, this means an original contribution to the research field of the analytical mechanics of variable-mass systems. We will start establishing the Poisson brackets definition for the dynamics of a position-dependent mass particle, which will be posited in harmony with the classical mathematical portrait of analytical mechanics. Therefrom, we will demonstrate consequent results which give rise to the required formulation, namely, Jacobi's identity, canonical equations expressed by means of such Poisson brackets and Poisson's theorem. Last, we will apply Poisson's theorem to evaluate the relationship between the conservation laws which are at our disposal in the domain of position-dependent mass problems.
引用
收藏
页码:1097 / 1097
页数:1
相关论文
共 50 条
  • [41] POSSIBLE RELATION BETWEEN HLA AND ABO TYPE AND PROGNOSIS OF UVEAL MELANOMA
    JAGER, MJ
    VOLKERDIEBEN, HJ
    DEWOLFFROUENDAAL, D
    KAKEBEEKEKEMME, H
    DAMARO, J
    DOCUMENTA OPHTHALMOLOGICA, 1992, 82 (1-2) : 43 - 47
  • [42] Very long-term prognosis of patients with malignant uveal melanoma
    Kujala, E
    Mäkitie, T
    Kivelä, T
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (11) : 4651 - 4659
  • [43] HLA Class I expression: Marker of poor prognosis in uveal melanoma
    Blom, DJR
    Luyten, GPM
    Mooy, CM
    Kerkvliet, S
    Zwinderman, AH
    Jager, MJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 3740 - 3740
  • [44] Genetic Basis and Molecular Mechanisms of Uveal Melanoma Metastasis: A Focus on Prognosis
    Gallenga, Carla Enrica
    Franco, Elena
    Adamo, Ginevra Giovanna
    Violanti, Sara Silvia
    Tassinari, Paolo
    Tognon, Mauro
    Perri, Paolo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Tumor thickness and gene expression profiling in estimating uveal melanoma prognosis
    Bakhsh, Saaquib
    Spektor, Tatyana
    Cohen, Jack
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [46] COX-2 expression in human uveal melanoma: Implication for prognosis
    Cryan, LM
    Paraoan, L
    Hiscott, P
    Grierson, I
    Damato, BE
    Farrell, M
    Doherty, G
    Fitzgerald, DJ
    O'Brien, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [47] Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis
    Pan, Hui
    Lu, Linna
    Cui, Junqi
    Yang, Yuan
    Wang, Zhaoyang
    Fan, Xianqun
    AGING-US, 2020, 12 (02): : 1446 - 1464
  • [48] Forty-year prognosis after plaque brachytherapy of uveal melanoma
    Gustav Stålhammar
    Scientific Reports, 10
  • [49] Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis
    Sisley, K
    Rennie, IG
    Parsons, MA
    Jacques, R
    Hammond, DW
    Bell, SM
    Potter, AM
    Rees, RC
    GENES CHROMOSOMES & CANCER, 1997, 19 (01): : 22 - 28
  • [50] The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
    Issam Salah, Nour El Imane
    Marnissi, Farida
    Lakhdar, Abdelhakim
    Karkouri, Mehdi
    Elbelhadji, Mohamed
    Badou, Abdallah
    FRONTIERS IN IMMUNOLOGY, 2023, 14